Drugs for Hyperlipidemia

Описание к видео Drugs for Hyperlipidemia

Official Ninja Nerd Website: https://ninjanerd.org
You can find the NOTES and ILLUSTRATIONS for this lecture on our website at:
https://www.ninjanerd.org/lecture/dru...

Ninja Nerds!
In this lecture Professor Zach Murphy will be presenting on Drugs for Hyperlipidemia. During this lecture we will start with reviewing the basic pathophysiology of Hyperlipidemia. After we review Hyperlipidemia Pathophysiology, we will be moving into the various drug categories that are used to treat Hyperlipidemia including: HMG CoA Reductase Inhibitors, Niacin, Fibrates, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, and PCSK9 Inhibitors. As always, we will be including 10 practice problems at the conclusion of this lecture to truly master this topic. We hope you enjoy this lecture and be sure to support us below!

Table of Contents:
0:00 Lab
0:07 Drugs for Hyperlipidemia Introduction
0:32 Pathophysiology of Hyperlipidemia
20:01 HMG-CoA Reductase Inhibitors
34:38 Niacin
46:30 Fibrates
57:32 Bile Acid Sequestrants
1:11:23 Cholesterol Absorption Inhibitors
1:18:35 PCSK-9 Inhibitors
1:23:57 Approach to Lipid Lowering Therapy
1:31:30 Combo Therapy
1:36:54 Drugs for Hyperlipidemia Practice Problems
1:43:24 Comment, Like, SUBSCRIBE!

Join this channel to get access to perks:
   / @ninjanerdofficial  

Pharmacology Source:
Whalen, Karen. Lippincott Illustrated Reviews: Pharmacology (Lippincott Illustrated Reviews Series). Wolters Kluwer Health. Kindle Edition.

APPAREL |
https://shop.ninjanerd.org
https://www.amazon.com/s?k=ninja+nerd...

PODCAST |
Apple Podcast: https://podcasts.apple.com/us/podcast...
Spotify: https://open.spotify.com/show/2ZDXoak...
Google Podcast: https://podcasts.google.com/feed/aHR0...

DONATE
PAYPAL | https://www.paypal.com/paypalme/ninja...

SOCIAL MEDIA

FACEBOOK |   / ninjanerdlectures  

INSTAGRAM |   / ninjanerdlectures  

TWITTER |   / ninjanerdsci  
@NinjaNerdSci

DISCORD |   / discord  

#ninjanerd #hyperlipidemia #cholesterol

Комментарии

Информация по комментариям в разработке